Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Bristol Myers Squibb
BMY Rank #93 Health Care
$62.03 -0.55%

Key Statistics

Market Cap
$126.30B
Volume (24h)
$894.1M
P/E Ratio
17.9
EPS
$3.47
1 Day
-0.55%
7 Day
+2.26%
YTD
+4.52%
Sector
Health Care
S&P 500 Rank
#93
52W Low: $54.26 52W High: $72.28

About Bristol Myers Squibb

Bristol Myers Squibb is a biopharmaceutical company that develops, manufactures, and markets prescription medicines for various diseases, including cancer, cardiovascular disease, and immunologic disorders. The company's key products include Opdivo, Revlimid, and Eliquis, which are used to treat a range of conditions, including lung cancer, multiple myeloma, and blood clots. As a leading player in the pharmaceutical industry, Bristol Myers Squibb plays a significant role in advancing medical research and improving patient outcomes.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,027.59 -2.32% JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% AMGN — Amgen $384.71 -0.89% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.